Current Hypertension Reports

, Volume 8, Issue 5, pp 398–402 | Cite as

Review of resistant hypertension

  • C. Venkata S. Ram
Article

Abstract

Despite the prevalence of hypertension, blood pressure (BP) can be controlled with effective therapy in most patients. However, in a small percentage of the hypertensive population, BP remains refractory to therapeutic measures. In such patients who have so-called “istant” hypertension, proper evaluation and assessment have to be undertaken to improve the BP control. There are some situations or factors that may make hypertension control difficult in some patients. Therefore, it is necessary to identify possible reasons for the loss of BP control and rectify them to achieve normotension. In addition to indicated work-up for secondary causes, aggressive treatment (nonpharmacologic and pharmacologic) of hypertension is required to prevent excessive morbidity and mortality in this special population.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Thibonnier M: Ambulatory blood pressure monitoring: When is it warranted? Postgrad Med 1992, 91:263–274.PubMedGoogle Scholar
  2. 2.
    Veglio F, Rabbia F, Riva P, et al.: Ambulatory blood pressure monitoring and clinical characteristics of the true and white-coat resistant hypertension. Clin Exp Hypertens 2001, 23:203–211.PubMedCrossRefGoogle Scholar
  3. 3.
    Verdecchia P: Using out of office blood pressure monitoring in the management of hypertension. Curr Hypertens Rep 2001, 3:400–405.PubMedGoogle Scholar
  4. 4.
    Messerli FH, Ventura HO, Amodeo C: Osler’s maneuver and pseudohypertension. N Engl J Med 1985, 312:1548–1551.PubMedCrossRefGoogle Scholar
  5. 5.
    Mejia AD, Egan BM, Schork NJ, Zweifler AJ: Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatmentresistant hypertension. Ann Intern Med 1990, 112:270–277.PubMedGoogle Scholar
  6. 6.
    Dustan HP, Tarazi RM, Bravo EL: Dependence of arterial pressure on intravascular volume in treated hypertensive patients. N Engl J Med 1972, 286:861–866.PubMedGoogle Scholar
  7. 7.
    Fierro-Carrion G, Ram CVS: Nonsteriodal anti-inflammatory drugs (NSAIDs) and blood pressure. Am J Cardiol 1980, 80:775–776.CrossRefGoogle Scholar
  8. 8.
    Bloxham CA, Beevers DG, Walker JM: Malignant hypertension and cigarette smoking. Br Med J 1997, 1:581–583.Google Scholar
  9. 9.
    Lavie P, Hoffstein V: Sleep apnea syndrome: a possible contributing factor to resistant hypertension. Sleep 2001, 24:721–725.PubMedGoogle Scholar
  10. 10.
    Tuomilehto J, Enlund H, Salonen JG, Nissinen A: Alcohol, patient compliance and blood pressure control in hypertensive patients. Scand J Soc Med 1984, 12:177–181.PubMedGoogle Scholar
  11. 11.
    Van JaarsveldBC, Krijnen P, Derkx FH, et al.: Resistance to antihypertensive medication as predictor of renal artery stenosis: comparison of two drug regimens. J Hum Hypertens 2001, 15:669–676.PubMedCrossRefGoogle Scholar
  12. 12.
    Addison C, Varney S, Coats A: The use of ambulatory blood pressure monitoring in managing hypertension according to different treatment guidelines. J Hum Hypertens 2001, 15:535–538.PubMedCrossRefGoogle Scholar
  13. 13.
    Felmeden DC, Lip GY: Resistant hypertension and the Birmingham Hypertension Square. Curr Hypertens Rep 2001, 3:203–208.PubMedGoogle Scholar
  14. 14.
    Nuesch R, Schroeder K, Dieterle T, et al.: Relation between insufficient response to antihypertensive treatment and poor compliance with treatment: a prospective case-control study. BMJ 2001, 323:142–146.PubMedCrossRefGoogle Scholar
  15. 15.
    Chobanian AV, Bakris, GL, Black HR, et al.: Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National Heat, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension 2003, 41:1206–1252. The latest report from the Joint National Committee, which includes a description of refractory hypertension.CrossRefGoogle Scholar
  16. 16.
    Graves J: Management of difficult-to-control hypertension. Mayo Clin Proc 2000, 75:278–284.PubMedCrossRefGoogle Scholar
  17. 17.
    Setaro J, Black H: Refractory hypertension. N Engl J Med 1992, 327:534–547.CrossRefGoogle Scholar
  18. 18.
    Eraker S, Kirscht J, Becker M: Understanding and improving patient compliance. Ann Intern Med 1984, 100:258–268.PubMedGoogle Scholar
  19. 19.
    Cuspidi C, Macca G, Sampieri L, et al.: High prevalence of Cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001, 19:2063–2070.PubMedCrossRefGoogle Scholar
  20. 20.
    Sartori M, Calo LA, Mascagna V, et al.: Aldosterone and refractory hypertension: a prospective cohort study. Am J Hypertens 2006, 19:373–379.PubMedCrossRefGoogle Scholar
  21. 21.
    Gaddam KK, Pratt-Ubunama MN, Calhoun DA: Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension. Expert Rev Cardiovasc Ther 2006, 4:353–359.PubMedCrossRefGoogle Scholar
  22. 22.
    Calhoun DA: Use of aldosterone antagonists in resistant hypertension. Prog Cardiovasc Dis 2006, 48:387–396. A rationale for the application of aldosterone antagonists is discussed in this publication.PubMedCrossRefGoogle Scholar
  23. 23.
    Wolk R, Somers VK: Obesity-related cardiovascular disease: implications of obstructive sleep apnea. Diabetes Obes Metab 2006, 8:250–260.PubMedCrossRefGoogle Scholar
  24. 24.
    Drager LF, Pereira AC, Barreto-Filho JA, et al.: Phenotypic characteristics associated with hypertension in patients with obstructive sleep apnea. J Hum Hypertens 2006, 20:523–528. Provides a description of patients with resistant hypertension who have sleep apnea syndrome.PubMedCrossRefGoogle Scholar
  25. 25.
    Norman D, Loredo JS, Nelesen RA, et al.: Effects of continuous positive airway pressure versus supplemental oxygen on 24 hour ambulatory blood pressure. Hypertension 2006, 47:840–845.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  • C. Venkata S. Ram
    • 1
  1. 1.Texas Blood Pressure InstituteDallasUSA

Personalised recommendations